182499-80-5

Basic information

• Product Name: Benzenamine, 2,2'-dithiobis[4-bromo-
• CAS NO: 182499-80-5
• Molecular Formula: C12H10Br2N2S2
• Molecular Weight: 406.165
• Mol File: 182499-80-5.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: Benzenamine, 2,2'-dithiobis[4-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2,2'-dithiobis[4-bromo-(182499-80-5)
• EPA Substance Registry System: Benzenamine, 2,2'-dithiobis[4-bromo-(182499-80-5)

Safety Data

• Hazardous Substances Data: 182499-80-5(Hazardous Substances Data)

Upstream product

• 15864-32-1 2-amino-6-bromobenzothiazole 
• 321-23-3 4-bromo-2-fluoronitrobenzene 
• 23451-95-8 2-amino-5-bromobenzenethiol 
• 62266-82-4 6-bromo-1,3-benzothiazol-2(3H)-one 
• 106-40-1 4-bromo-aniline 
• 1306756-67-1 N,N'-(2,2'-disulfanediylbis(4-bromo-2,1-phenylene))diformamide 

Downstream Products

• 23451-95-8 2-amino-5-bromobenzenethiol 
• 875895-87-7 [2-(2-amino-5-bromo-phenylsulfanylmethyl)-phenyl]-methanol 
• 875895-75-3 2-(2-amino-5-bromo-phenylsulfanylmethyl)-benzoic acid methyl ester 
• 791614-78-3 ethyl 2-(6-bromobenzo[d]thiazol-2-yl)acetate 
• 791614-79-4 7-bromo-3-hydroxy-4H-benzo[1,4]thiazine-2-carboxylic acid ethyl ester 
• 1235453-34-5 6-bromo-2-(2-chlorophenyl)benzo[d]thiazole 
• 1235453-31-2 6-bromo-2-(4-iodophenyl)benzo[d]thiazole 
• 566169-97-9 2-(4’-aminophenyl)-6-bromobenzothiazole 
• 10544-50-0 sulfur 
• 51618-30-5 6-bromo-2-mercaptobenzothiazole 

Relevant articles and documents

Development of a radioiodinated thioflavin-T-Congo-red hybrid probe for diagnosis of systemic amyloidosis

Introduction: Systemic amyloidosis is a group of diseases characterized by the deposition of amyloid protein in multiple organs throughout the body and causing their dysfunction. As amyloid deposition is observed at an early phase and is highly specific t

Scalable synthesis of a cis-substituted cyclobutyl-benzothiazole pyridazinone: Process development of an efficient copper catalyzed C-N cross-coupling reaction

A scalable process for the preparation of 2-(2-(cis-3-(piperidin-1-yl) cyclobutyl)benzothiazol-6-yl)pyridazin- 3(2H)-one in multi-kilogram amounts and in high purity has been developed. The key features of this synthesis are the coppercatalyzed C-N cross-

Fluorescence properties of 5-(5,6-dimethoxybenzothiazol-2-yl)-2′- deoxyuridine (dbtU) and oligodeoxyribonucleotides containing d btU

We describe the synthesis and photophysical properties of 11 substituted 5-(benzothiazol-2-yl)-2′-deoxyuridine derivatives and oligodeoxyribonucleotides (ODNs) containing 5-(5,6-dimethoxybenzothiazol-2-yl)- 2′-deoxyuridine (dbtU), which was the strongest fluorescent derivative among those prepared. The fluorescence properties of dbtU itself and ODNs containing dbtU show the same tendency of being weaker in both neutral and acidic solution and stronger in basic solution. The ODNs (15mer) containing 16 combinations of 5′-XbtU-3′ and 5′-btUY-3′, where X, Y = A, T, G, or C, were synthesized, and their fluorescence intensity and quantum yield in basic solution were compared. On average, only the ODN with the 5′-G btU-3′ sequence shows a 7.9-fold lower fluorescence intensity than the other sequences. Ab initio calculations of 5′-G btU-3′ and 5′-btUG-3′ as models under basic conditions suggest that the lower fluorescence of the ODN containing the 5′-GbtU-3′ sequence is caused by a wider overlap between stacked guanine (Gua) and btUra than that of the 5′- btUG-3′ sequence and that the HOMO is delocalized not only on btUra but also on Gua.